Published: 2019-01-25

Carcinogenic herbs: a review

Ishan Tewari, Prashant Shukla, Vijay K. Sehgal


Herbal toxicity is a field that has rapidly grown over the last few years along with increased use of herbal products worldwide. People prefer using herbal medicines rather than allopathic because herbals are considered safe. Use of herbal medicines from ancient times does not ensure their complete safety. With the growing awareness regarding pharmacovigilance worldwide, there has been an increase in the number of reported adverse events occurring with the use of herbal products. The objective of the study is to aware the researchers about most commonly used Indian medicinal herbs inducing carcinogenicity like Aloe vera, Ginkgo biloba, Kava kava, etc. 


Aloe vera, Carcinogenicity, Ginkgo biloba, herbals, Kava kava

Full Text:



Bagozzi MD. New WHO guidelines to promote proper use of alternative medicines, WHO, 2004. Available at: Accessed on May 03, 2017.

Tovar RT, Petzel RM. Herbal Toxicity. Disease-a- Month. 2009;55:592-641.

Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Ind J Dermatol. 2008;53:163-6.

Boudreau MD, Mellick PW, Olson GR, Felton RP, Thorn BT, Beland FA. Clear evidence of carcinogenic activity by a whole leaf extract of aloe barbadenis miller (Aloe vera) in F344/N rats. Toxicological Sciences. 2013;131:26-39.

Yokohira M, Matsuda Y, Suzuki S, Hosokawa K, Yamakawa K, Hashimoto N, et al. Equivocal colonic carcinogenicity of Aloe arborescens Miller var. natalensis Berger at high-dose level in a Wistar Hannover rat 2-y study. J Food Sci. 2009;74:2:24-30.

Zhiyan Z, Shaolin Z. Palaeobiology: The missing link in Ginkgo evolution. Nature. 2003;423(6942):821-2.

Jalalpour J, Malkin M, Poon P, Rehrmann L, Yu J. Ginkgoales: Fossil Record. University of California, Berkeley; 1997.

Mahadevan S, Park Y. Multifaceted therapeutic benefits of Ginkgo biloba L.: Chemistry, Efficacy, Safety, and Uses. J Food Sci. 2007;73:14-9.

Hecker H, Johannisson R, Koch E, Siegers CP. In vitro evaluation of the cytotoxic potential of alkylphenols from Ginkgo biloba L. Toxicol. 2002;177(2-3):167-77.

Chan PC, Rider CV, Nyska A. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies). National Toxicology Program technical report series. 2013;1-183.

Rider CV, Nyska A, Cora MC, Kissling GE, Smith C, Travlos GS, et al. Toxicity and carcinogenicity studies of ginkgo biloba extract in rat and mouse: liver, thyroid, and nose are targets. Toxicologic Pathol. 2014 Jul;42(5):830-43.

Savage KM, Stough CK, Byrne GJ. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial. Trials. 2015;16:493.

Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS. Kava lactones and the kava-kava controversy. Phytochemistry. 2003 Oct;64(3):673-9.

Prescott J. Kava use in Australia. Drug Alcohol Rev. 1990;9:325-8.

Behl M, Nyska A, Chhabra RS, Travlos GS, Fomby LM, Sparrow BR et al. Liver toxicity and carcinogenicity in F344/N rats and B6C3F1Mice exposed to kava kava. Food Chem Toxicol. 2011;49(11):2820-9.

Ettefagh KA, Burns JT, Junio HA, Kaatz GW, Cech NB. Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition. Planta Medica. 2011;77(8):835-40.

McKenna DJ, Jones K, Hughes K. Botanical Medicines: The Desk Reference for Major Herbal Supplements 2002. 2nd ed. Haworth Press, Binghamton, NY; 2002:547-568.

Abidi P, Chen W, Kraemer FB, Li H, Liu J. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms. J Lipid Res. 2006;47:10:2134-47.

Chen S, Wan L, Couch L, Lin H, Li, Dobrovolsky VN, et al. Mechanism study of goldenseal-associated DNA damage. Toxicology Letters. 2013;221:64-72.

Dunnick JK, Peckham JC, Bishop JB. Toxicology and carcinogenesis studies of goldenseal root powder (Hydrastis Canadensis) in F344/N rats and B6C3F1 mice (feed studies). National Toxicology Program Technical Report Series. 2010;562:1-188.

Kupchan SM, Doskotch RW. Tumor inhibitors. I. aristolochic acid, the active principle of Aristolochia indica. J Med Pharma Chem. 1962;91:657-9.

Zhang H, Cifone MA, Murli H, Erexson GL, Mecchi MS, Lawlor TE. Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid. Food Chem Toxicol. 2004;42:2021-8.

Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New Eng J Med 2000;342:1686-92.

Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 1996;56:2025-8.

Nesslany F, Zennouche N, Simar-Meintieres S, Talahari I, Nkili-Mboui EN, Marzin D. In vivo comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds. Mutation Res. 2007;630(1-2):28-41.

Wu K, Jiang L, Cao J, Yang G, Geng C, Zhong L. Genotoxic effect and nitrative DNA damage in HepG2 cells exposed to aristolochic acid. Mutation Res. 2007;630:97-102.

Li Y, Liu Z, Guo X, Shu J, Chen Z, Li L. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Archives Toxicol. 2006;80:524-32.

Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001;37:6:477-92.

Gupta PC, Ray CS. Epidemiology of betel quid usage. Annals Academy Medicine, Singapore. 2004;33:4:31-6.

Bhat, R, Ganachari, S, Deshpande R, Ravindra, G, Venkataraman A. Rapid Biosynthesis of Silver Nanoparticles Using Areca Nut (Areca catechu) Extract Under Microwave-Assistance. J Cluster Sci. 2012;24:107.

Kaushal M, Mishra AK, Raju BS, Ihsan R, Chakraborty A, Sharma J, et al. Betel quid chewing as an environmental risk factor for breast cancer, Mutation Res. 2010;703(2):143-8.

Tsai JF, Jeng JE, Chuang LY, Ho MS, Ko YC, Lin ZY, et al. Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis, Medicine (Baltimore). 2004;83(3):176-87.

Yen AM, Chen SC, Chen TH. Dose-response relationships of oral habits associated with the risk of oral pre-malignant lesions among men who chew betel quid. Oral Oncol. 2007;43(7):634-8.

Chiu CC, Chen BH, Hour TC, Chiang WF, Wu YJ, Chen CY, et al. Betel quid extract promotes oral cancer cell migration by activating a muscarinic M4 receptor-mediated signalling cascade involving SFKs and ERK1/2, Biochemical and Biophysical Research Commun. 2010;399(1):60-5.

Bhide SV, Shivapurkar NM, Gothoskar SV, Ranadive KJ. Carcinogenicity of betel quid ingredients: feeding mice with aqueous extract and the polyphenol fraction of betel nut. Bri J Cancer. 1979;40(6):922-6.

Dave BJ, Trivedi AH, Adhvatyu SG. Role of areca nut consumption in the cause of oral cancers. A cytogenetic assessment. Cancer. 1992;70(5):1017-23.

Chen YJ, Liao CT, Chen PJ, Lee LY, Li YC, Chen IH, et al. Downregulation of Ches1 and other novel genes in oral cancer cells chronically exposed to areca nut extract. Head and Neck. 2011;33(2):257-66.

Sundqvist K, Grafstrom RC. Effects of areca nut on growth, differentiation and formation of DNA damage in cultured human buccal epithelial cells. Int J Cancer. 1992;52(2):305-10.

Tsai NM, Lin SZ, Lee CC, Chen SP, Su HC, Chang WL, Harn HJ. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo. Clin Cancer Res. 2005 May 1;11(9):3475-84.

Lin PC, Liu PY, Lin SZ, Harn HJ. Angelica sinensis: a Chinese herb for brain cancer therapy. BioMedicine. 2012 Mar 1;2(1):30-5.

Staiger C. Comfrey: a clinical overview. Phytother Res. 2012;26(10):1441-8.

Mei N, Guo L, Fu PP, Heflich RH, Chen T. Mutagenicity of comfrey (Symphytum Officinale) in rat liver. Br J Cancer. 2005;92(5):873-5.

Hirono I, Mori H, Haga M. Carcinogenic activity of Symphytum officinale. J Natl Cancer Inst. 1978;61(3):865-9.

Blömeke B, Poginsky B, Schmutte C, Marquardt H, Westendorf J. Formation of genotoxic metabolites from anthraquinone glycosides, present in Rubia tinctorum L. Mutat Res. 1992;265(2):263-72.

Inoue K, Yoshida M, Takahashi M, Fujimoto H, Ohnishi K, Nakashima K, et al. Possible contribution of rubiadin, a metabolite of madder color, to renal carcinogenesis in rats. Food Chem Toxicol. 2009;47(4):752-9.

Inoue K, Yoshida M, Takahashi M, Fujimoto H, Shibutani M, Hirose M, et al. Carcinogenic potential of alizarin and rubiadin, components of madder color, in a rat medium-term multi-organ bioassay., Cancer Sci. 2009;100(12):2261-7.

Westendorf J, Poginsky B, Marquardt H, Groth G, Marquardt H. The genotoxicity of lucidin, a natural component of Rubia tinctorum L., and lucidinethylether, a component of ethanolic Rubia extracts, Cell Biol Toxicol. 1988 Jun;4(2):225-39.

Poginsky B, Westendorf J, Blömeke B, Marquardt H, Hewer A, Grover PL, Phillips DH. Evaluation of DNA-binding activity of hydroxyanthraquinones occurring in Rubia tinctorum L. Carcinogenesis. 1991 Jul;12(7):1265-71.

Blömeke B, Poginsky B, Schmutte C, Marquardt H, Westendorf J. Formation of genotoxic metabolites from anthraquinone glycosides, present in Rubia tinctorum L. Mutat Res. 1992 Feb;265(2):263-72.